Patent · US Active

Microneedle system for applying a hepatitis vaccine

US12168053B2 · kind B2 · utility

0Cited by

2References

13Claims

0Family size

Assignee

LTS Lohmann Therapie-Systeme AG · DE

Inventors

Andreas Henning · Meßstetten, DE
Heiko Spilgies · Koblenz, DE

Key dates

Filing date	Nov 12, 2018
Grant date	Dec 17, 2024
Priority date	—
Expiry date	Nov 10, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2730/10134
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a microneedle system (MNS for short) for the intradermal application of a hepatitis vaccine, namely the antigen HBsAg.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.